pivekimab sunirine
immunogen
['cadenza', 'pivekimab', 'immunogen ', '$imgn']
immunogen presents updated findings from cadenza trial of pivekimab sunirine in blastic plasmacytoid dendritic cell neoplasm at eha 2023 congress - health stocks hub $imgn 
Real-Time News, Market Data, Insider Trades, and Stock Quotes for Biotech, Pharma, Medical, and Healthcare Stocks @ https://t.co/Oqp6BRBKy2